SNDX Competitors & Alternatives
Compare Syndax Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
SNDX
Main Stock$23.61
Tradestie Score
62
Market Cap
$1.35B
Revenue Growth
2.2%
Analyst Upside
+65.2%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.65
|
$2.35B | - | 57 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.22
|
$2.34B | - | 57 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.59
|
$2.33B | - | 63 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$41.23
|
$2.33B | - | 57 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.56
|
$2.23B | - | 58 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.06
|
$2.22B | - | 60 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.59
|
$2.21B | - | 63 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.68
|
$2.18B | - | 63 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.44
|
$2.08B | - | 63 | Compare |
More SNDX Analysis
Data updated: Jul 12, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry